Elise Deluche (E Deluche)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Locally Advanced

Radiofrequency Ablation

Neoadjuvant Chemotherapy

Top Venues

Medical oncology (Northwood, London, England)

Journal of personalized medicine

Future oncology (London, England)

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Clara Naessens, Jerome Laloze, Sophie Leobon, Tristan Gauthier, Aymeline Lacorre, Jacques Monteil, Laurence Venat, Elise Deluche
Physician compliance with multidisciplinary tumor board recommendations for managing gynecological cancers. Future oncology (London, England) (2023)
Fernanda Mosele, Elise Deluche, Amelie Lusque, Loïc Le Bescond, Thomas Filleron, Yoann Pradat, Agnes Ducoulombier, Barbara Pistilli, Thomas Bachelot, Frederic Viret, Christelle Levy, Nicolas Signolle, Alexia Alfaro, Diep T N Tran, Ingrid Judith Garberis, Hugues Talbot, Stergios Christodoulidis, Maria Vakalopoulou, Nathalie M Droin, Aurelie Stourm, Maki Kobayashi, Tomoya Kakegawa, Ludovic Lacroix, Patrick Saulnier, Bastien Job, Marc Deloger, Marta Jimenez, Thierry Petit, Vianney Baris, Pierre Laplante, Patricia L Kannouche, Virginie Marty, Magali Lacroix-Triki, Véronique Diéras, Fabrice Andre
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial. Nature medicine (2023)
Delphine Hequet, N Hajjaji, E Charafe-Jauffret, A Boucrauta, F Dalenc, V Nicolai, J Lopez, O Tredan, Elise Deluche, V Fermeaux, L Tixier, A Cayre, E Menet, F Lerebours, R Rouzier
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings. Cancer medicine (2023)
François Vincent, Elise Deluche, Joëlle Bonis, Sophie Leobon, Marie-Thérèse Antonini, Caroline Laval, Florent Favard, Eloïse Dobbels, Sandrine Lavau-Denes, Anaïs Labrunie, Frédéric Thuillier, Laurence Venat, Nicole Tubiana-Mathieu
Home-Based Physical Activity in Patients With Breast Cancer: During and/or After Chemotherapy? Impact on Cardiorespiratory Fitness. A 3-Arm Randomized Controlled Trial (APAC). Integrative cancer therapies 19 (2021)
Elise Deluche, Tiffany Darbas, Kevin Bourcier, Loic Montangon, Geraldine Bayard, Evelyne Caille, Julie Querrioux, Chantal Suchaud, Sonia Zabaleta, Sabine Chaput, Valerie Le Brun-Ly, Julia Pestre, Laurence Venat Bouvet, Frédéric Thuillier, Elodie Nevado, Gaelle Maillan, Jeremy Jost, Sophie Leobon, Nicole Tubiana-Mathieu, Sandrine Lavau-Denes
Prospective evaluation of an anti-cancer drugs management programme in a dedicated oral therapy center (DICTO programme). Medical oncology (Northwood, London, England) 37 (8) (2020)
Camille Duhamel, Mirela Diana Ilie, Henri Salle, Adjoa Sika Nassouri, Stephan Gaillard, Elise Deluche, Richard Assaker, Laurent Mortier, Christine Cortet, Gerald Raverot
Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature. Journal of personalized medicine 10 (3) (2020)
Kevin Bourcier, Veronique Fermeaux, Sophie Leobon, Elise Deluche
Lobular Breast Carcinoma Metastasis to the Thyroid Gland: Case Report and Literature Review. Journal of breast cancer 21 (4) (2018)